Compounds > brimonidine tartrate
Page last updated: 2024-08-23

brimonidine tartrate and Eye Diseases

brimonidine tartrate has been researched along with Eye Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alió, JL; Cuenca, N; Fernández-Sanchez, L; Gandara-Loe, J; Ortuño-Lizarán, I; Silvestre-Albero, J; Vega-Estrada, A1
Donald, CB; Mendez, AP; Pierce, BD1
Bowman, RJ; Cope, J; Nischal, KK1
Gordon, RN; Greenfield, DS; Lama, P; Liebmann, JM; Ritch, R1
Lagrèze, WA1

Trials

1 trial(s) available for brimonidine tartrate and Eye Diseases

ArticleYear
Lack of cross-reactive allergic response to brimonidine in patients with known apraclonidine allergy.
    Eye (London, England), 1998, Volume: 12 ( Pt 4)

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Clonidine; Cross Reactions; Drug Hypersensitivity; Eye Diseases; Follow-Up Studies; Glaucoma; Humans; Middle Aged; Quinoxalines; Time Factors

1998

Other Studies

5 other study(ies) available for brimonidine tartrate and Eye Diseases

ArticleYear
OTC brimonidine (Lumify) for ocular redness.
    The Medical letter on drugs and therapeutics, 2018, Oct-22, Volume: 60, Issue:1558

    Topics: Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Eye Diseases; Humans; Nonprescription Drugs; Ophthalmic Solutions; Treatment Outcome

2018
Metal-Organic Frameworks as Drug Delivery Platforms for Ocular Therapeutics.
    ACS applied materials & interfaces, 2019, Jan-16, Volume: 11, Issue:2

    Topics: Animals; Brimonidine Tartrate; Cell Line, Tumor; Drug Carriers; Eye; Eye Diseases; Metal-Organic Frameworks; Mice; Organometallic Compounds

2019
Eye problems in a woman with Churg-Strauss syndrome.
    JAAPA : official journal of the American Academy of Physician Assistants, 2017, Volume: 30, Issue:2

    Topics: Administration, Ophthalmic; Antihypertensive Agents; Brimonidine Tartrate; Chronic Disease; Churg-Strauss Syndrome; Edema; Exophthalmos; Eye Diseases; Eyelids; Female; Glucocorticoids; Humans; Latanoprost; Methylprednisolone; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic

2017
Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
    Eye (London, England), 2004, Volume: 18, Issue:1

    Topics: Adolescent; Adrenergic alpha-Agonists; Antihypertensive Agents; Brimonidine Tartrate; Child; Child, Preschool; Eye Diseases; Female; Glaucoma; Humans; Infant; Infant, Newborn; Male; Ophthalmic Solutions; Quinoxalines; Sleep Stages; Syncope

2004
[Neuroprotection. Bases and possibilities of a future clinical use].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2001, Volume: 98, Issue:3

    Topics: Adrenergic alpha-Agonists; Animals; Apoptosis; Brimonidine Tartrate; Clinical Trials as Topic; Disease Models, Animal; Dopamine Agents; Eye Diseases; Forecasting; Glaucoma; Humans; Memantine; Neuroprotective Agents; Optic Neuritis; Quinoxalines; Retinal Diseases; Visual Fields

2001